Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 451 - 475 of 8035 in total
Tafasitamab is a humanized, CD19-directed cytolytic monoclonal antibody intended for the treatment of B-cell malignancies. It is produced using recombinant DNA technology in Chinese hamster ovary cells, and contains an IgG1/2 hybrid Fc-domain which has been modified with 2 amino acid substitutions to enhance its cytotoxicity relative to non-engineered anti-CD19...
Approved
Investigational
Matched Description: … results in the lysis of B-cells (both healthy and malignant). ... Tafasitamab is a humanized, CD19-directed cytolytic monoclonal antibody intended for the treatment of ... [L15292,A191829] The CD19 surface protein is highly expressed on the surface of B-cells, where it …
Birch bark extract is rich in triterpenoids with beneficial biological and pharmacological activities. Some of the compounds identified in it include betulin, lupeol, betulinic acid, oleanolic acid, and erythrodiol. Birch bark extract is obtained from the white part of the birch tree bark, and the main species of trees used...
Approved
Experimental
Matched Description: … [L42380] Two oleogel formulations of birch bark extract (Oleogel-S10, 10% of triterpene dry extract in ... wounds in patients with epidermolysis bullosa (EB), a rare group of hereditary disorders of the skin ... [L42365,L42370] Filsuvez, one of these two formulations, is approved for the treatment of partial thickness …
A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Approved
Vet approved
Matched Description: … A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of
Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine.[A228423, A228763] Scopolamine was first synthesized in 1959, but to date, synthesis remains less efficient than extracting scopolamine from plants. As an acetylcholine...
Approved
Investigational
Matched Description: … Scopolamine is a tropane alkaloid isolated from members of the _Solanaceae_ family of plants, similar ... to [atropine] and [hyoscyamine], all of which structurally mimic the natural neurotransmitter [acetylcholine ... [A228423, A228758] As a result of its anticholinergic effects, scopolamine is being investigated for …
Nalmefene, a 6-methylene analogue of naltrexone, is an opioid receptor antagonist. It acts as an antagonist at the mu (μ)-opioid and delta (δ)-opioid receptors and a partial agonist at the kappa (κ)-opioid receptor. In Europe, nalmefene oral tablets are used to reduce alcohol consumption in adults with alcohol dependence. Nalmefene...
Approved
Investigational
Withdrawn
Matched Description: … Nalmefene, a 6-methylene analogue of [naltrexone], is an opioid receptor antagonist. ... [L40684] The nasal spray formulation of nalmefene was approved by the FDA in May 2023.[L46511] ... It is used for complete or partial reversal of opioid drug effects, including respiratory depression, …
Tamoxifen is a non-steroidal antiestrogen used to treat estrogen receptor positive breast cancers as well as prevent the incidence of breast cancer in high risk populations.[A1025,L7799,L7802] Tamoxifen is used alone or as an adjuvant in these treatments.[L7799,L7802] Tamoxifen may no longer be the preferred treatment for these types of cancers...
Approved
Matched Description: … antiestrogen used to treat estrogen receptor positive breast cancers as well as prevent the incidence of ... [L7799,L7802] Tamoxifen may no longer be the preferred treatment for these types of cancers as patients …
Filgrastim is a short-acting recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog produced by recombinant DNA technology. It has an amino acid sequence identical to endogenous G-CSF, but it is non-glycosylated unlike the endogenous G-CSF and has an N-terminal methionine added in the sequence for expression in E. Coli. Human...
Approved
Matched Description: … action of the drug. ... Filgrastim mimics the biological actions of G-CSF to increase the levels of neutrophils in the blood. ... [L40719] It has a number of therapeutic uses, including the management and prevention of infections and …
A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.
Approved
Investigational
Emapalumab, also known as NI-0501, is a fully human monoclonal antibody that targets interferon gamma. Emapalumab development was sponsored by NovImmune SA, further developed by Sobi and FDA approved on November 20, 2018.[A38676, L4840] The approval of emapalumab was followed by the designation of orphan drug, priority review and breakthrough...
Approved
Investigational
Matched Description: … [A38676, L4840] The approval of emapalumab was followed by the designation of orphan drug, priority review ... [L4840] As well, emapalumab was given the status of PRIME by the EMA.[L4845] …
Glycopyrronium, also known as NVA237 or glycopyrrolate, is a racemic mixture of two enantiomers. They are both quaternary ammonium compounds and long acting muscarinic antagonists. It is one of the most commonly prescribed anticholinergic medications.[A233535,A233540] Early research into glycopyrronium use was for its indication as an adjunct therapy in the...
Approved
Investigational
Vet approved
Matched Description: … [A233570,L33090] Later research, taking advantage of the systemic distribution of muscarinic receptors ... [L33110] It is one of the most commonly prescribed anticholinergic medications. ... Glycopyrronium, also known as NVA237 or glycopyrrolate, is a racemic mixture of two enantiomers. …
A topical glucocorticoid used in the treatment of eczema.
Approved
Investigational
Matched Description: … A topical glucocorticoid used in the treatment of eczema. …
Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direct thrombin inhibitor.[L41539,L41569] Natural hirudin is an endogenous anticoagulant found in Hirudo medicinalis leeches. Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of sulfate on...
Approved
Withdrawn
Matched Description: … This activates endothelial cells and platelets and enhances the formation of thrombi. ... [A246609] Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.[L41574] ... L41539] Lepirudin is produced in yeast cells and is identical to natural hirudin except for the absence of
Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competitively...
Approved
Matched Description: … studies to significantly reduce the risk of development of CVD and all-cause mortality. ... and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes ... This is the third step in a sequence of metabolic reactions involved in the production of several compounds …
Velmanase alfa is a recombinant human lysosomal alpha-mannosidase developed for enzyme replacement therapy to treat alpha-mannosidosis. Alpha-mannosidosis is a rare autosomal recessive lysosomal storage disorder. Patients with alpha-mannosidosis have a genetic mutation that causes a deficiency in the lysosomal enzyme alpha-mannosidase, which is an enzyme responsible for breaking down complex...
Approved
Investigational
Matched Description: … The resulting accumulation of sugars in the body leads to an array of clinical manifestations leading ... alpha-mannosidase for the treatment of alpha-mannosidosis. ... Commission in March 2018 under the market name Lamzede [L39754] as the first human recombinant form of
Micafungin is an antifungal drug. It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.
Approved
Investigational
Matched Description: … the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall. ... It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting …
Canagliflozin, also known as Invokana, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus along with lifestyle changes including diet and exercise [FDA label]. It was initially approved by the FDA in 2013 for the management of diabetes and later approved in 2018...
Approved
Matched Description: … for a second indication of reducing the risk of cardiovascular events in patients diagnosed with type ... Cardiovascular disease is the most common cause of death in these patients [A177083]. ... also known as _Invokana_, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the management of
Naxitamab (humanized 3F8, hu3F8) is an IgG1 monoclonal antibody directed against the oncofetal differentiation antigen GD2 disialoganglioside.[L24454,A224604] Normally expressed during fetal development and in mature neurons, pain fibers, and skin cells, GD2 constitutes a highly efficient target in the treatment of neuroblastoma - it is widely expressed across and within...
Approved
Matched Description: … of its predecessor. ... [A224474] One stark disadvantage of this therapy is the requirement for concurrent use of granulocyte-macrophage ... high-risk relapsed/refractory neuroblastoma of the bone or bone marrow. …
One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.
Approved
Matched Description: … One of the catecholamine neurotransmitters in the brain. ... A family of receptors (receptors, dopamine) mediate its action. ... Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating …
Albutrepenonacog alfa (rIX-RFP) is a recombinant fusion protein that links a recombinant coagulation factor IX (rFIX) with a recombinant human albumin (rAlbumin). It was developed by CSL Behring Canada, Inc and approved by Health Canada on April 26, 2017. It was also approved by FDA and EMA in 2016. It...
Approved
Matched Description: … It is currently marketed in the forms of 250, 500, 1000 and 2000 IU/vial.[L2305] …
Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly.[A214812,A214817] Complications in lc-FAOD patients...
Approved
Investigational
Matched Description: … Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long ... Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of
Ceftolozane is a semi-synthetic broad-spectrum fifth generation cephalosporin. It was approved by the FDA in 2014 for use in combination with Tazobactam for the treatment of serious infections, such as intra-abdominal infections and complicated urinary tract infections. The manufacturer of this drug is Cubist Pharmaceuticals. Most recently, in June 2019,...
Approved
Investigational
Matched Description: … The manufacturer of this drug is Cubist Pharmaceuticals. ... L6685] It was approved by the FDA in 2014 for use in combination with [Tazobactam] for the treatment of ... and mortality in hospitalized patients and the use of ceftolozane-tazobactam offers effective activity …
Glofitamab is a full-length bispecific monoclonal antibody with affinity for both CD20 and CD3 surface antigens found on B- and T-cells, respectively. It has a 2:1 configuration, with bivalency towards CD20 and monovalency towards CD3, and works by recruiting T-cells directly to the surface of cancerous B-cells.[L45698,A258488] Glofitamab was approved...
Approved
Investigational
Matched Description: … In June 2023, the FDA approved the use of glofitamab for the treatment of patients with relapsed or refractory ... systemic therapy under accelerated approval based on response rate and durability of response. ... [L45698,A258488] Glofitamab was approved by Health Canada in March 2023 for the treatment of certain …
Dyclonine is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. It may also be found in some Cepacol sore throat spray products.
Approved
Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension[FDA Label] . Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate .
Approved
Matched Description: … Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle …
Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond. Prednisolone acetate was granted FDA approval in 1955.
Approved
Vet approved
Displaying drugs 451 - 475 of 8035 in total